Haleon PLC Sponsored ADR (NYSE:HLN) Receives Average Rating of “Hold” from Analysts

Shares of Haleon PLC Sponsored ADR (NYSE:HLN) have been assigned an average rating of “Hold” from the eleven analysts that are covering the stock, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation, three have assigned a buy recommendation and two have issued a strong buy recommendation on the company.

Several research analysts have recently weighed in on the stock. Wall Street Zen raised shares of Haleon from a “hold” rating to a “buy” rating in a research report on Sunday, July 12th. Rothschild & Co Redburn cut shares of Haleon from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Morgan Stanley reaffirmed an “overweight” rating on shares of Haleon in a research note on Thursday, August 6th. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Tuesday, June 30th. Finally, Zacks Research cut shares of Haleon from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 21st.

Institutional Investors Weigh In On Haleon

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Fiduciary Financial Group LLC purchased a new stake in Haleon in the second quarter valued at $97,000. GAMMA Investing LLC grew its holdings in shares of Haleon by 18.1% during the 2nd quarter. GAMMA Investing LLC now owns 34,810 shares of the company’s stock worth $325,000 after purchasing an additional 5,338 shares during the period. Arlington Partners LLC increased its position in shares of Haleon by 23.0% during the 2nd quarter. Arlington Partners LLC now owns 29,826 shares of the company’s stock worth $278,000 after purchasing an additional 5,580 shares during the last quarter. Pacific Excel Wealth Advisors Inc. acquired a new stake in shares of Haleon during the 2nd quarter worth about $209,000. Finally, Hilltop National Bank raised its holdings in Haleon by 12.7% in the 2nd quarter. Hilltop National Bank now owns 15,672 shares of the company’s stock valued at $146,000 after buying an additional 1,771 shares during the period. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Up 0.1%

Shares of NYSE:HLN opened at $9.94 on Friday. Haleon has a 52-week low of $8.65 and a 52-week high of $11.28. The stock has a market cap of $43.76 billion, a P/E ratio of 25.47, a PEG ratio of 1.99 and a beta of 0.12. The business has a fifty day moving average of $9.56 and a two-hundred day moving average of $9.85. The company has a quick ratio of 0.52, a current ratio of 0.69 and a debt-to-equity ratio of 0.38.

Haleon Cuts Dividend

The firm also recently disclosed a dividend, which will be paid on Thursday, September 17th. Investors of record on Friday, August 14th will be issued a $0.0642 dividend. The ex-dividend date is Friday, August 14th. This represents a yield of 127.0%. Haleon’s dividend payout ratio is currently 64.10%.

About Haleon

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.